The global clinical trial imaging market is projected to reach USD 1.9 billion by 2028 from USD 1.3 billion in 2023, at a CAGR of 7.8%

during the forecast period. The market’s expansion is propelled by factors including the expansion of the pharmaceutical and biotechnology sectors, escalated research and development investments, and the proliferation of Contract Research Organizations (CROs).New York, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Clinical Trial Imaging Market by Software & Service, Modality, Therapeutic Area, End User & Region - Global Forecast to 2028" - https://www.re

Related Keywords

France ,Spain ,United Kingdom ,United States ,Boston ,Massachusetts ,Australia ,Ireland ,Canada ,New York ,Japan ,America ,Asia Pacific ,Metrics Inc ,Calyx Group United Kingdom ,Resonance Health Ltd ,Research Coverage ,Boston Imaging Core Lab ,Worldcare Clinical ,Biomedical Systems Corporation ,Prism Clinical Imaging Inc ,Bioseptive Inc ,Cardiovascular Imaging Technologies ,Imaging Endpoints ,Medpace Holdings Inc ,Contract Research Organizations Cros ,Company Type ,Micron Inc ,Bioclinica Inc ,Software Service ,Perspectum Ltd ,Biotelemetry Inc ,Market Development ,Product Development Innovation ,Intrinsic Imaging ,Lyscaut Medical Imaging Company Belgium ,Proscan Imaging ,Contract Research Organizations ,Trial Imaging Market ,Therapeutic Area ,End User ,North America ,Latin America ,Middle East ,Africa The Asia Pacific ,Medpace Holdings ,Resonance Health ,Radiant Sage ,Medical Metrics ,Prism Clinical Imaging ,Lyscaut Medical Imaging Company ,Calyx Group ,Entwicklung Gmbh ,Median Technologies ,Market Diversification ,Competitive Assessment ,Clinical Trial ,Medical Device Manufacturers ,Service Software ,Imaging Market ,Growth Rate ,